Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Regorafenib vs Placebo After Curative Resection of Liver Metastases in Stage IV Colorectal Cancer
2012-004369-42Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC) and metastatic colon cancer (mCRC) comparing Regorafenib arm with Placebo arm (2 arms). Primary endpoint: Disease-free survival. Started Sep 2013; status: completed.
02
Drugs
regorafenib
03
Conditions
colorectal cancer (CRC)metastatic colon cancer (mCRC)
Beyond the preview
Go deeper on 2012-004369-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004369-42.